Cite Filings / RLAY / 0000950170-22-018205

Feed Companies Filings Check

Sign in

8-K

Current Report

Relay Therapeutics, Inc. Filed 2022-09-08 Acc 0000950170-22-018205

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , rlay-20220907.htm

Around this filing

2022-09-12 424B5 Prospectus
2022-09-12 8-K Regulation FD disclosure · Other events
2022-09-08 4 Director sold 25,000 shares at $29.95 ($748,750)
2022-09-08 4 Chief Financial Officer sold 26,257 shares at $30.00 ($787,710)
2022-09-08 4 President, R&D sold 25,000 shares at $30.00 ($750,000)
2022-09-08 8-K Regulation FD disclosure
2022-08-04 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading rlay-20220907.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…